inTEST (NYSE:INTT) Stock Price Down 0.3% - Time to Sell?

inTEST Co. (NYSE:INTT - Get Free Report)'s stock price fell 0.3% on Wednesday . The company traded as low as $7.05 and last traded at $7.05. 9,438 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 49,806 shares. The stock had previously closed at $7.07.

Analyst Ratings Changes

INTT has been the subject of a number of recent research reports. Lake Street Capital reduced their target price on shares of inTEST from $10.00 to $8.00 and set a "buy" rating for the company in a report on Monday, May 5th. Northland Capmk downgraded shares of inTEST from a "strong-buy" rating to a "hold" rating in a report on Monday, May 5th.

inTEST Stock Up 1.7%

The firm has a market cap of $91.46 million, a PE ratio of 31.83 and a beta of 1.65. The business's 50 day moving average price is $6.76 and its 200 day moving average price is $7.30. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.26 and a quick ratio of 1.38.

inTEST (NYSE:INTT - Get Free Report) last released its earnings results on Friday, May 2nd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). inTEST had a return on equity of 5.31% and a net margin of 2.33%. During the same quarter in the previous year, the business posted $0.10 EPS. On average, equities research analysts expect that inTEST Co. will post 0.41 earnings per share for the current year.

Insider Activity

In other news, Director Gerald J. Maginnis acquired 7,557 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was purchased at an average price of $5.78 per share, with a total value of $43,679.46. Following the completion of the acquisition, the director owned 78,057 shares of the company's stock, valued at $451,169.46. This trade represents a 10.72% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 7.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Pacific Ridge Capital Partners LLC boosted its stake in shares of inTEST by 6.6% in the fourth quarter. Pacific Ridge Capital Partners LLC now owns 582,483 shares of the company's stock valued at $5,004,000 after purchasing an additional 36,031 shares during the period. Russell Investments Group Ltd. boosted its stake in shares of inTEST by 208.9% in the fourth quarter. Russell Investments Group Ltd. now owns 43,543 shares of the company's stock valued at $374,000 after purchasing an additional 29,445 shares during the period. Northern Trust Corp boosted its stake in shares of inTEST by 8.2% in the fourth quarter. Northern Trust Corp now owns 40,328 shares of the company's stock valued at $346,000 after purchasing an additional 3,048 shares during the period. Jane Street Group LLC boosted its stake in shares of inTEST by 9.0% in the fourth quarter. Jane Street Group LLC now owns 31,644 shares of the company's stock valued at $272,000 after purchasing an additional 2,602 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in shares of inTEST by 43.2% in the fourth quarter. Ameriprise Financial Inc. now owns 493,524 shares of the company's stock valued at $4,239,000 after purchasing an additional 148,784 shares during the period. Hedge funds and other institutional investors own 63.18% of the company's stock.

About inTEST

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.